These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
85 related articles for article (PubMed ID: 1017467)
1. Radiopaque contrast media. XLII-Metabolism of iopronic acid in human. Pitrè D; Felder E Farmaco Prat; 1976 Oct; 31(10):540-6. PubMed ID: 1017467 [No Abstract] [Full Text] [Related]
2. Radiopaque contrast media. XL- Isolation and identification of the metabolites of iopronic acid in the urine and bile of the dog. Pitrè Farmaco Prat; 1976 Oct; 31(10):516-28. PubMed ID: 1017465 [No Abstract] [Full Text] [Related]
3. Radiopaque contrast media. XLI-Isolation and identification of the metabolites of iopronic acid in the rat. Pitrè D; Fumagalli L Farmaco Prat; 1976 Oct; 31(10):529-39. PubMed ID: 1017466 [No Abstract] [Full Text] [Related]
5. Radiopaque contrast media. XXXIX - Metabolism of iopronic acid by rat liver microsomes: characterization and identification of the metabolites. Pitrè D; Facino RM Farmaco Sci; 1976 Oct; 31(10):755-62. PubMed ID: 1010025 [TBL] [Abstract][Full Text] [Related]
6. In vitro binding and metabolism of iopronic acid by rat liver microsomes. Raffaeli E; Facino RM; Salmona M; Pitré D Pharmacol Res Commun; 1977 Oct; 9(9):833-46. PubMed ID: 609577 [No Abstract] [Full Text] [Related]
13. Radiopaque contrast media. XXXVIII - Iopronic acid, a new contrast medium for oral cholecystography: toxicologic investigation. Tirone P; Rosati G Farmaco Prat; 1976 Sep; 31(9):437-46. PubMed ID: 1010018 [No Abstract] [Full Text] [Related]
14. Radiological contrast mediums. XIX. Urinary metabolites of iodoxanic acid in man. Pitrè D; Fumagalli L; Fonberg-Broczek M Farmaco Sci; 1971 Oct; 26(10):882-90. PubMed ID: 5157787 [No Abstract] [Full Text] [Related]
15. [Results and conclusions from metabolic studies of I 131 -falignost]. Barke R; Hieckel HG Radiol Diagn (Berl); 1972; 13(6):805-15. PubMed ID: 4657544 [No Abstract] [Full Text] [Related]
16. The fate of an experimental MAO inhibitor, N-cyclopropyl-2-chlorophenoxyethylamine (Lilly 51641) in the rat and in man. Sullivan HR; Billings RE; Fasola AF; McMahon RE Xenobiotica; 1971 Nov; 1(6):621-30. PubMed ID: 5173025 [No Abstract] [Full Text] [Related]